Chemical formula: C₅₂H₇₈N₁₀O₁₇ Molecular mass: 1,115.249 g/mol PubChem compound: 131704326
Controlled trials monitoring foetal risk and impairment of fertility in humans are not available. Therefore, inosine pranobex should not be administered during pregnancy unless the physician decides the benefits outweigh the potential risk.
Although animal tests have shown no teratogenic effect, the use of inosine pranobex in women where pregnancy is suspected or confirmed should be avoided.
It is not known if inosine pranobex is excreted in human milk. Therefore, inosine pranobex should not be administered during lactation unless the physician decides the benefits outweigh the potential risk.
Inosine pranobex has no or negligible influence on the ability to drive and use machines.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
